Pfizer net profit declines 56.11 pc to Rs 220.85 cr in FY14

Pharma major Pfizer Ltd today said its net profit declined by 56.11 per cent to Rs 220.85 crore in the financial year ended March 2014.
The company had reported a net profit of Rs 503.20 crore in the year ended March 2013.
The company reported 3.66 per cent decline in net profit at Rs 56.03 crore for the quarter ended March 2014 as compared to Rs 58.16 crore in the same period last year, a company statement said.
The revenue for the quarter ended March 2014 was Rs 251.69 crore as compared to Rs 252.19 crore in the same period last year. The revenue for the year FY'14 was Rs 1,004.27 crore as compared to Rs 947.98 crore in last year.

Excluding the transitional support for sales of certain animal health products, the pharmaceutical revenue for the quarter registered a growth of 6 per cent to Rs 251.69 crore as compared to Rs 237.24 crore in the same period last year.
Similarly, revenue for the year registered a growth of 5 per cent to Rs 961.80 crore as compared to Rs 915.06 crore last year.

Profit before tax and exceptional items for the year grew by 21 per cent to Rs 339.58 crore from Rs 279.65 crore last year.
Earnings per share before exceptional items improved to Rs 74.01 per equity share for the year from Rs 61.10 per equity share last year.

The company had paid an interim dividend of Rs 360 per equity share of Rs 10 each during the financial year ended March 2014.